← FDA DRUG APPROVALS

FDA ANDA · ANDA202393

DICLOFENAC SODIUM

Sponsor: TWI PHARMS

APPLICATION
ANDA202393
TYPE
ANDA
ORIGINAL APPROVAL
2014-11-24
LATEST ACTION
2021-04-28
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

DICLOFENAC SODIUMDiscontinued
DICLOFENAC SODIUM 1.5% · SOLUTION · TOPICAL

Approval history

2021-04-28Labeling · Supplement 2 · standardAP
2021-04-01Labeling · Supplement 1 · standardAP
2014-11-24UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →